Phase I/II trial of induction chemotherapy followed by concurrent chemoradiotherapy and surgery for locoregionally Advanced Pancreatic Cancer

Annals of Surgical Oncology

Volumn 15, Issue 12, 2008, Pages 3521-3531

  Marti, Jennifer L ^a   Hochster, Howard S ^a   Hiotis, Spiros P ^a   Donahue, Bernadine ^a,b   Ryan, Theresa ^a   Newman, Elliot ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Maimonides Cancer Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; DOCETAXEL; DOXIFLURIDINE; FLUOROURACIL; FOLINIC ACID; GEMCITABINE; MITOMYCIN C; PACLITAXEL; STREPTOZOCIN;

ABDOMINAL PAIN; ADULT; ADVANCED CANCER; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANEMIA; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CHYLOUS ASCITES; CLINICAL ARTICLE; CLINICAL TRIAL; COHORT ANALYSIS; DIARRHEA; DISEASE COURSE; DRUG DOSE ESCALATION; DRUG DOSE REDUCTION; FATIGUE; FEASIBILITY STUDY; FEMALE; FEVER; GASTROINTESTINAL SYMPTOM; HUMAN; HUMAN TISSUE; HYPERBILIRUBINEMIA; INFECTION; INTESTINE PERFORATION; LEUKOPENIA; MALE; MUCOSA INFLAMMATION; MULTIPLE CYCLE TREATMENT; NAUSEA AND VOMITING; NEUTROPENIA; OVERALL SURVIVAL; PANCREAS CARCINOMA; PANCREAS FISTULA; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; RADIATION DOSE; RECOMMENDED DRUG DOSE; SIDE EFFECT; SKIN TOXICITY; THROMBOCYTOPENIA;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COMBINED MODALITY THERAPY; DEOXYCYTIDINE; FEMALE; FLUOROURACIL; HUMANS; MALE; MAXIMUM TOLERATED DOSE; MIDDLE AGED; NEOPLASM STAGING; PANCREATIC NEOPLASMS; REMISSION INDUCTION; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 58149311234     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-008-0152-3     Document Type: Article

References (58)

1. A Jemal A Thomas T Murray 2002 Cancer Statistics CA Cancer J Clin 52 23 47
2. V Heinemann D Quietzsch F Gieseler 2006 Randomized Phase III trial of gemcitabine pulse cisplatin compared with gemcitabine alone in advanced pancreatic cancer J Clin Oncol 24 3946 52
3. SR Bramhall WH Allum AG Jones 1985 Treatment and survival in 13,560 patients with pancreatic cancer, and incidence of disease, in the west midlands: an epidemiological study Br J Sur 82 111 5
4. S Parker T Tong S Bolden 1997 Cancer statistics CA Cancer J Clin 47 5 27
5. M Trede G Schwal H Saeger 1990 Survival after pancreaticoduodenectomy Ann Surg 211 447 58
6. National Cancer Institute: Surveillance, Epidemiology, and End Results (SEER)*Stat 6.1 Database: Incidence-SEER 9 Regs Public Use, Bethesda, MD, National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch. Nov 2004 Sub (1973-2002)
7. National Comprehensive Cancer Network (NCCN). Pancreatic adenocarcinoma. Practice Guidelines in Oncology. v.1.2008. Fort Washington, PA. http://www.nccn.org/professionals/physician-gls/PDF/pancreatic.pdf
8. P Massuco L Capussotti A Magnino 2006 Pancreatic resections after chemotherapy for locally advanced ductal adenocarcinoma: analysis of perioperative outcome and survival Ann Surg Oncol 13 1201 8
9. M Talamonti W Small M Mulcahy 2005 A Multi-institutional Phase II trial of preoperative full-dose gemcitabine and concurrent radiation for patients with potentially resectable pancreatic carcinoma Ann Surg Oncol 13 150 8
10. FR Spitz JL Abbruzzese JE Lee 1997 Preoperative and postoperative chemoradiation strategies in patients treated with pancreaticoduodenectomy for adenocarcinoma of the pancreas J Clin Oncol 15 928 37
11. J Hoffman S Lipsitz T Pisansky 1998 Phase II trial of preoperative radiation therapy and chemotherapy for patients with localized, resectable adenocarcinoma of the pancreas: an Eastern Cooperative Oncology Group study J Clin Oncol 16 317 23
12. CG Moertel S Frytak RG Hahn 1981 Therapy of locally unresectable pancreatic carcinoma: a randomized comparison of high dose (6000 rads) radiation alone, moderate dose radiation (4000 rads + 5-fluorouracil), and high dose radiation + 5-fluorouracil Cancer 48 1075 10
13. Gastrointestinal Tumor Study Group 1988 Treatment of locally unresectable carcinoma of the pancreas: comparison of combined-modality therapy (chemotherapy plus radiotherapy) to chemotherapy alone J Natl Cancer Inst 80 751 5
14. JB Ammori LM Colletti MM Zalupski 2003 Surgical resection following radiation therapy with concurrent gemcitabine in patients with previously unresectable adenocarcinoma of the pancreas J Gastrointest Surg 7 766 72
15. C Chao J Hoffman E Ross 2000 Pancreatic carcinoma deemed unresectable at exploration may be resected for cure: an institutional experience Am Surg 66 378 87
16. RR White HI Hurwitz MA Morse 2001 Neoadjuvant chemoradiation for localized adenocarcinoma of the pancreas Ann Sur Oncol 8 758 65
17. HJ Kim K Czischke MF Brennan 2002 Does neoadjuvant chemoradiation downstage locally advanced pancreatic cancer? J Gastrointest Surg 6 763 9
18. JD Berlin P Catalano JP Thomas 2002 Phase III study of gemcitabine in combination with fluorouracil versus gemcitabine alone in patients with advanced pancreatic carcinoma: Eastern Cooperative Oncology Group Trial E2297 J Clin Oncol 20 3270 5
19. MJ Moore J Hamm J Dancey 2003 Comparison of gemcitabine versus the matrix metalloproteinase inhibitor BAY 12-9566 in patients with advanced or metastatic adenocarcinoma of the pancreas: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group J Clin Oncol 21 3296 302
20. L Rocha M Green R Roche 2004 Irinotecan plus gemcitabine results in no survival advantage compared with gemcitabine monotherapy in patients with locally advanced or metastatic pancreatic cancer despite increased tumor response rate J Clin Oncol 22 3776 83
21. SR Bramhall J Schultz J Nemunaitis 2002 A double-blind placebo-controlled, randomised study comparing gemcitabine and marimastat with gemcitabine and placebo as first line therapy in patients with advanced pancreatic cancer Br J Cancer 87 161 7
22. Bramhal SR, Rosemurgy A, Brown PD, Marimastat Pancreatic Cancer Study Group. Marimastat as first-line therapy for patients with unresectable pancreatic cancer: a randomized trial. J Clin Oncol 2001; 19:3477-55
23. E Van Cutsem H van de Velde P Karase 2004 Phase III trial of gemcitabine plus tipifarnib compared with gemcitabine plus placebo in advanced pancreatic cancer J Clin Oncol 22 1430 8
24. O'Reilly EM, Abou-Alfa GK, Letorneau R, et al. A randomized phase III trial of DX-8951f (exatecan mesylate) and gemcitabine vs gemcitabine alone in advanced pancreatic cancer. Proc Am Soc Clin Oncol 2004; 23:abstr 4006
25. Richards DA, Kindler HL, Oettle H, et al. A randomized phase III study comparing gemcitabine + pemetrexed versus gemcitabine in patients with locally advanced and metastatic pancreas cancer. Proc Am Soc Clin Oncol 2004; 23:abstr 4007
26. Louvet C, Labianca R, Hammel P, et al. GemOx (gemcitabine + oxaliplatin) versus Gem (gemcitabine) in non-resectable pancreatic adenocarcinoma: final results of the GERCOR/GISCAD Intergroup phase III. Proc Am Soc Clin Oncol 2004; 23:abstr 4008
27. HA Burris MJ Moore J Anderson 1997 Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial J Clin Oncol 15 2403 13
28. A Bergman V van Ruiz Haperen G Veerman 1996 Synergistic interaction between cisplatin and gemcitabine in vitro Clin Cancer Res 2 521 30
29. T Lawrence E Chang T Hahn 1996 Radiosensitization of pancreatic cancer cells by 2′,-difluoro-2′deoxycytidine Int J Radiat Oncol Biol Phys 34 867 72
30. B Pauwels A Korst F Lardon 2005 Combined modality therapy of gemcitabine and radiation Oncologist 10 34 51
31. R Wilkowski M Thoma R Schauer 2004 Effect of chemoradiotherapy with gemcitabine and cisplatin on locoregional control in patients with primary inoperable pancreatic cancer World J Surg 28 1011 8
32. DG Haller 2003 Chemotherapy for advanced pancreatic cancer Int J Radiat Oncol Biol Phys 56 16 23
33. V Heinemann 2002 Gemcitabine based combination treatment of pancreatic cancer Semin Oncol 29 25 35
34. M Reni S Cordio C Milandri 2005 Gemcitabine versus cisplatin epirubicin, fluorouracil, and gemcitabine in advanced pancreatic cancer: a randomised controlled multicentre phase III trial Lancet Oncol 6 369 76
35. Gastrointestinal Tumor Study Group. A multi-institutional comparative trial of radiation therapy alone and in combination with 5-FU for locally unresectable pancreatic cancer. Am Surg 1979;189:205-11
36. L Cora L Coffman R Sher 1994 Preoperative chemoradiation for adenocarcinoma of the pancreas and duodenum Int J Radiat Oncol Biol Phys 30 161 7
37. E Bajetta M Di Bartolomeo SC Stani 1999 Chemotherapy as preoperative treatment in locally advanced unresectable pancreatic cancer patients: results of a feasibility study J Radiat Oncol Biol Phys 45 285 9
38. Jessup JM, Steele, Mayer RJ, et al. Neoadjuvant therapy for unresectable pancreatic adenocarcinoma. Arch Surg 1993; 128:559-64
39. AG Kamthan J Morris J Dalton 1997 Combined modality therapy for stage II and stage III pancreatic carcinoma J Clin Oncol 15 2920 7
40. E Poplin T Corbett L Flaherty 1992 Difluorodeoxycytidine (dFDC)-gemcitabine: a phase I study Invest New Drugs 10 165 70
41. M Rothenberg M Moore M Cripps 1996 A phase II trial of gemcitabine in patients with 5-FU refractory pancreas cancer Ann Oncol 7 347 53
42. C McGinn D Smith C Ozark's 1998 A phase I study of gemcitabine in combination with radiation therapy in patients with localized, unresectable pancreatic cancer Proc ASCO 17 264a
43. C McGinn M Zalupski I Shureiqi 2001 A phase I trial of radiation dose escalation with concurrent weekly full dose gemcitabine in patients with advanced pancreatic cancer J Clin Oncol 19 4202 8
44. A Eisbruch D Shewach C Bradford 2001 Radiation concurrent with gemcitabine for locally advanced head and neck cancer: a phase I trial and intracellular drug incorporation study J Clin Oncol 19 792 9
45. D Evans T Rich D Byrd 1992 Preoperative chemoradiation and pancreaticoduodenectomy for adenocarcinoma of the pancreas Arch Surg 127 1335 9
46. PW Pisters JL Abbruzzese NA Janjan 1998 Rapid-fractionation preoperative chemoradiation, pancreaticoduodenectomy and intraoperative radiation therapy for resectable pancreatic adenocarcinoma J Clin Oncol 16 3843 50
47. Abou-Alfa GK, Letourneau R, Harker G, et al. O'Reilly EM. Randomized phase III study of exatecan and gemcitabine compared with gemcitabine alone in untreated advanced pancreatic cancer. J Clin Oncol 2006; 4:4441-7
48. R Yeung J Weese J Hoffman 1993 Neoadjuvant chemoradiation in pancreatic and duodenal carcinoma. A phase II study Cancer 72 2124 33
49. JL Weese ML Nussbaum AR Paul 1990 Increased resectability of locally advanced pancreatic and periampullary carcinoma with neoadjuvant chemoradiotherapy Int J Pancreatol 7 177 85
50. R White C Lee M Anscher 1999 Preoperative chemoradiation for patients with locally advanced adenocarcinoma of the pancreas Ann Surg Oncol 6 38 45
51. JR Delpero O Turrini 2006 Locally advanced pancreatic adenocarcinoma. Chemoradiotherapy, reevaluation and secondary resection Cancer Radiother 10 462 70
52. X Adhoute D Smith V Vendrely 2006 Subsequent resection of locally advanced pancreatic carcinoma after chemoradiotherapy Gastroenterol Clin Biol 30 224 30
53. A Sa Cunha A Rault C Laurent 2005 Surgical resection after radiochemotherapy in patients with unresectable adenocarcinoma of the pancreas Am Coll Surg 201 359 65
54. HJ Wanebo AS Glicksman MP Vezeridis 2000 Preoperative chemotherapy, radiotherapy, and surgical resection of locally advanced pancreatic cancer Arch Surg 135 81 7
55. HG Rau MW Wichmann R Wilkowski 2002 Surgical therapy of locally advanced and primary inoperable pancreatic carcinoma after neoadjuvant preoperative radio chemotherapy Chirurg 73 132 7
56. J Aristu R Canon F Pardo 2003 Surgical resection after preoperative chemoradiotherapy benefits selected patients with unresectable pancreatic cancer Am J Clin Oncol 26 30 6
57. CH Crane JL Abbruzzeze DB Evans 2002 Is the therapeutic index better with Gemcitabine-based chemoradiation than with 5-FU-based chemoradiation in LAPC? Int J Radiat Oncol Biol Phys 52 1293 302
58. RR White DS Tyler 2004 Neoadjuvant therapy for pancreatic cancer: the Duke experience Surg Oncol Clin N Am 13 675 84